Four times faster than conventional PCR methods, new RADICA approach is highly specific, sensitive, and resistant to inhibitors.
How 3D-printed models of neuronal axons could accelerate development of new therapies to treat neurodegenerative disorders.
The sensor technology could also be used to create clothing that detects a variety of pathogens and other threats.
Professor Tim Jamison’s company Snapdragon Chemistry helps turn the latest innovations in chemistry into impactful drugs.
Novel method, developed by McGovern Institute researchers, may lead to safer, more efficient gene therapies.
Ten principal investigators from seven MIT departments and labs will receive up to $150,000 for two years, overhead-free, for innovative research on global food and water challenges.
Nearly 1,400 joined the AI for Health Care Equity Conference that explored new AI technologies as a platform for change.
Professor Markus Buehler composed it, and a South Korean orchestra performed it; it’s the latest in a series of artistic collaborations sparked by Buehler’s exploration of the structure of SARS-CoV-2.
Covid-19 class taps experts to help students and the public avoid misinformation as the crisis evolves.
The student pitch competition addressed a variety of problems expected to worsen with climate change.
KSQ Therapeutics uses technology created at MIT to study the role of every human gene in disease biology.
MIT researchers have developed a publicly available model based on physics and data from past spreading events.